Clinical Trial Update: RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ranibizumab with laser therapy for retinopathy of prematurity has completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Retinopathy of Prematurity | Phase 3 | Status: COMPLETED | Results posted: 2018-07-31